Brief: Iconovo Starts Talks On Potential Licensing Agreement For Its Icopre Inhaler
11/01/2023 08:13
Jan 11 (Reuters) - Iconovo AB ICO.ST :
* ENTERED NEGOTIATIONS WITH GLOBAL PHARMACEUTICAL COMPANY
FOR
POTENTIAL LICENSING AGREEMENT FOR ITS ICOPRE INHALER
* PURPOSE OF NEGOTIATIONS IS TO ENTER LICENSE AGREEMENT FOR
DEVELOPMENT, COMMERCIALIZATION OF ONE OR MORE PRODUCTS BASED ON
CO'S INHALER ICOPRE
* THERE IS NO GUARANTEE THAT THESE NEGOTIATIONS WILL LEAD TO
ACTUAL AGREEMENT BETWEEN COMPANIES
Source text for Eikon: ID:nMFN1YyBsS
Further company coverage: ICO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))